Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb;105(2):265-268.
doi: 10.1016/j.pec.2021.05.026. Epub 2021 May 21.

Endorsement of COVID-19 related misinformation among cancer survivors

Jeanine P D Guidry  1 , Kellie E Carlyle  2 , Carrie A Miller  2 , Albert J Ksinan  3 , Robert Winn  4 , Vanessa B Sheppard  5 , Bernard F Fuemmeler  5
Affiliations

Endorsement of COVID-19 related misinformation among cancer survivors

Jeanine P D Guidry et al. Patient Educ Couns. 2022 Feb.

Abstract

Objectives: To determine whether cancer survivors currently in treatment are more or less likely to endorse COVID-19 related misinformation compared to their counterparts no longer in treatment and those without a cancer history.

Methods: We conducted a Qualtrics survey among 897 adults to determine differences in endorsement of COVID-19 misinformation among cancer survivors in active treatment, cancer survivors no longer in treatment, and a control group with no cancer history.

Results: Cancer survivors currently undergoing treatment were more likely to believe misinformation related to COVID-19 than those without a cancer history. Least likely to endorse COVID-19 misinformation were cancer survivor no longer in treatment.

Conclusion: These results alert healthcare professionals to overall high levels of endorsement of COVID-19 misinformation among cancer survivors on active treatment. Oncologists and other providers working with patients undergoing treatment for cancer should be particularly mindful of the potential elevated beliefs in misinformation among this group.

Practical implications: Since patients undergoing cancer treatment seem to be particularly vulnerable to COVID-19 misinformation, oncologists and other healthcare providers working with this patient population should help address patients' concerns about the pandemic and how it relates to their course of treatment.

Keywords: COVID-19; Cancer; Misinformation.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
The standardized results from the structural model. Note. Model fit: χ2 (359) = 1096.45, p < .001, CFI = 0.91, RMSEA = 0.05 [.045,.051], SRMR = 0.034. Reference group for dummy-coded sex = male; dummy-coded education = high school; reference group for dummy-coded race/ethnicity = White; reference group for dummy-coded treatment status = no cancer. *p < .05, ***p < .001.
See this image and copyright information in PMC

References

    1. Brennen J.S., Simon F., Howard P.N., Nielsen R.K. Types, sources, and claims of Covid-19 misinformation. Reuters Inst. 2020;7(3):1.
    1. Brainard J., Hunter P.R. Misinformation making a disease outbreak worse: outcomes compared for influenza, monkeypox, and norovirus. Simulation. 2020;96(4):365–374. - PMC - PubMed
    1. Nannyonga BK, Wanyenze RK, Kaleebu P, et al. Infodemic: How an Epidemic of Misinformation Could Lead to a High Number of the Novel Corona Virus Disease Cases in Uganda; 2020.
    1. Ahmed W., Vidal-Alaball J., Downing J., Seguí F.L. COVID-19 and the 5G conspiracy theory: social network analysis of Twitter data. J Med Internet Res. 2020;22(5):19458. - PMC - PubMed
    1. Lewandowsky S., Ecker U.K., Seifert C.M., Schwarz N., Cook J. Misinformation and its correction: continued influence and successful debiasing. Psychol Sci Public Interest. 2012;13(3):106–131. - PubMed

Publication types